Greenland Mines Secures Australian Patent for Klotho Gene Therapy
Greenland Mines Ltd (NASDAQ: GRML) announces Australian patent covering Klotho gene therapy for ALS and neuromuscular diseases, strengthening its biotech IP portfolio.
This patent grant strengthens Greenland Mines' intellectual property in gene therapy for neuromuscular diseases, including ALS, potentially accelerating development of treatments for conditions with high unmet need. For investors, it solidifies the company's biotech division value and may attract partnership or licensing interest, while for patients, it offers hope for novel therapies targeting fatal disorders like ALS.
